Abingworth LLP
Investor profile
Abingworth LLP has backed 5 European tech companies across 6 funding rounds between 2013 and 2021, joining rounds totalling €244M. Most active in Healthtech. Data as of Nov 2026.
Also recorded as: Abingworth
Deals
6
distinct rounds
Companies
5
backed
Active span
2013–2021
9 yrs
Total round €
€244M
sum of rounds joined
Deals by year
distinct rounds / yearAbingworth LLP — deals by year — interactive chart.
Data table
| Abingworth LLP — deals by year | |
|---|---|
| 2013 | 1 |
| 2015 | 3 |
| 2017 | 1 |
| 2021 | 1 |
Top sectors
by dealsAbingworth LLP — top sectors — interactive chart.
Data table
| Abingworth LLP — top sectors | |
|---|---|
| Healthtech | 6 |
Stages
by dealsAbingworth LLP — stages — interactive chart.
Data table
| Abingworth LLP — stages | |
|---|---|
| Series A | 3 |
| Series B | 3 |
Countries
by dealsAbingworth LLP — countries — interactive chart.
Data table
| Abingworth LLP — countries | |
|---|---|
| Switzerland | 3 |
| France | 2 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| GenSight Biologics | France | 2 | €64M |
| CRISPR Therapeutics | Switzerland | 1 | €59M |
| Anjarium Biosciences | Switzerland | 1 | €51M |
| Nouscom | Switzerland | 1 | €42M |
| Kesios Therapeutics | UK | 1 | €27M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| CRISPR Therapeutics | Series B | €59M | 2015-04 |
| Anjarium Biosciences | Series A | €51M | 2021-09 |
| Nouscom | Series B | €42M | 2017-11 |
| GenSight Biologics | Series B | €32M | 2015-07 |
| GenSight Biologics | Series A | €32M | 2013-04 |
| Kesios Therapeutics | Series A | €27M | 2015-12 |